Tilray Medical
Sydney, New South Wales, Australia · Agriculture and Farming, Analytics, Biotechnology
Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with a focus on cannabis, beverage, wellness, and entertainment. The company aims to elevate lives through moments of connection, offering a house of brands and innovative products. Tilray operates in Canada, the United States, Europe, Australia, and Latin America, supporting over 40 brands across more than 20 co
Key facts
- Headquarters
- Sydney, New South Wales, Australia
- Employees
- 1
- Industries
- Agriculture and Farming, Analytics, Biotechnology
- Status
- Public (TLRY)
- Website
- tilray.com
- Company page
Recent activity at Tilray Medical
- : Biogen completes acquisition of RayThera Inc.
- : MGP Ingredients Appoints Tom Neiheisel as Vice-President of Distilling Solutions Sales
- : Onex to acquire AirSprint in Q3 completion
- : Tilray Brands acquires HelloMD to enhance patient access
- : FitLife Brands acquires Irwin Naturals successfully
- : Assertio completes merger with Zydus Lifesciences
- : Carriage Services acquires McCammon Ammons Click Funeral Home
- : SEC 8-K (1.01): On April 15, 2026, Tilray Brands, Inc. entered into an Open Market Sale Agreement with Jefferies LLC, TD Securities (USA) LLC, and Roth Capital Partners, LLC, allowing the company to sell its common stock worth up to $180,000,000. The sales can be conducted through the agents as sales agents or directly to them as principals, following the 'at the market offering' method as outlined in Rule 415(a)(4) of the Securities Act of 1933. This agreement provides Tilray with a flexible capital-raising mechanism to support its business operations and growth strategies.
- : SEC 8-K (1.01): On April 15, 2026, Tilray Brands, Inc. entered into a Material Definitive Agreement with Jefferies LLC, TD Securities (USA) LLC, and Roth Capital Partners, LLC for an Open Market Sale Agreement allowing the company to offer and sell shares of its common stock with an aggregate offering price of up to $180,000,000. This agreement permits the sales to be conducted as 'at the market offerings' as defined by Rule 415(a)(4) under the Securities Act of 1933. The arrangement is significant as it provides Tilray with flexible capital raising options through its Agents, impacting the company's liquidity and capital structure for future operational needs.
- : Routeware acquires PermiServ for UK expansion
Leadership
- Adam Kramer, Director - ANZ (Country Manger)
- Michael Auerbach, Director
- Brendan Kennedy, Executive Officer, Director
- Kelly Rooney, Chief Operating Officer
- Brian Keith, Chief Digital Officer
- Christopher Copeland, Chief Innovation Officer
- David Sanders, President
- Tom Neiheisel, President
- Michael J. Parini, Chief Legal Officer
- Zach Sawtelle, Chief Operating Officer
- Binglin Yu, Chief Technology Officer
- Loïc Gautier, Chief Financial Officer
Verified email and direct lines for Tilray Medical’s decision-makers are on Fundz. See plans
Tilray Medical in the news
- Tilray's playbook for medical marijuana expansion - MJBizDaily (May 07, 2026)
- Tilray Medical Accelerates Commercial Expansion in UK With Direct-to-Patient Launch - Cannabis Business Times (Aug 17, 2026)
- Trump's Marijuana Rescheduling Push Is Back in Focus. Is Tilray Stock Finally a Buy? - The Motley Fool (Sep 15, 2026)
- Tilray Medical Germany Launches ARX™, a New Premium Medical Cannabis Brand Cultivated in Germany - Yahoo Finance (Jun 10, 2026)
- Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand - GlobeNewswire (Aug 20, 2026)
- Tilray acquires UK medical cannabis firm, files $180M equity program - Investing.com (Apr 15, 2026)
- Tilray launches first medical cannabis brand cultivated in Germany - MMJDaily (Jun 11, 2026)
- Cannabis Stocks Rise and Fall on Rescheduling News; Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) Rollercoaster Morning - Investorideas.com (Apr 23, 2026)
Companies similar to Tilray Medical
- Tasso · Biotechnology, Education, Health Care, Information Technology, Other, Software
- Telepatía AI · Biotechnology, Health Care, Information Technology, Medical, Software
- ClinOne, Inc. · Biotechnology, Health Care, Medical, Other, Software
- IM Cannabis Corp · Biotechnology, Cannabis, Health Care, Medical, Other
- Focus Medical Herbs Ltd · Agriculture and Farming, Biotechnology, Cannabis, Health Care, Medical
About Tilray Medical: questions and answers
What does Tilray Medical do?
Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with a focus on cannabis, beverage, wellness, and entertainment. The company aims to elevate lives through moments of connection, offering a house of brands and innovative products. Tilray operates in Canada, the United States, Europe, Australia, and Latin America, supporting over 40 brands across more than 20 co
Where is Tilray Medical headquartered?
Tilray Medical is headquartered in Sydney, New South Wales, Australia.
How many employees does Tilray Medical have?
Tilray Medical has about 1 employees.
Who leads Tilray Medical?
David Sanders is a President at Tilray Medical.
What is the latest news on Tilray Medical?
On Aug 06, 2026, Biogen completes acquisition of RayThera Inc.
Is Tilray Medical a public company?
Yes. Tilray Medical is publicly traded under the ticker TLRY.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy